Choose Language Donate to Illuminate Contact TSF
Visit us on Facebook Visit us on Twitter Visit us on YouTube Visit us on Instagram Visit us on Linkedin

Choose Your Language:

Chinese (Simplified) Chinese (Simplified) Chinese (Traditional) Chinese (Traditional) Danish Danish Dutch Dutch English English French French German German Italian Italian Portuguese Portuguese Spanish Spanish

Patient Assistance

PAN Foundation

The PAN Foundation and The Sumaira Foundation (TSF) launched a new partnership to help people living with neuromyelitis optica spectrum disorder (NMOSD), providing up to $9,600 per year in financial assistance and support services for patients and their caregivers or loved ones.

Neuromyelitis optica spectrum disorder (NMOSD), also known as Devic’s disease and neuromyelitis optica, is a rare and recurring autoimmune disease where an individual’s immune system attacks its own cells in the central nervous system, mainly in the optic nerves and spinal cord, and sometimes in the brain as well.

The National Organization for Rare Disorders estimates that between one and 10 of every 100,000 people are living with neuromyelitis optica spectrum disorder worldwide.  

“PAN’s mission is to ease the burden of out-of-pocket costs and support each patient holistically, and we are grateful for the support of our alliance partners and the services they provide,” said PAN President and CEO Kevin L. Hagan. “The expertise and resources provided by The Sumaira Foundation will be a great benefit to those living with NMOSD.”

Industry Partners

Community Partners

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.